Stage at diagnosis only partly explains the wide variation in lung cancer survival rates among different developed countries, indicates a large study of nearly 60,000 patients, published online in Thorax.
Other factors, such as treatment, are also likely to have a key role, say the authors.
Stage at diagnosis has often been suggested as one of the primary reasons why lung cancer survival is low in certain countries, such the UK, on the grounds that patients go to see their doctors too late for treatment to be effective.